USPTO serial 98485502
REGENACR
Reviewed by CopyMark Law Group
Status 731Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- MARTIN, JENNIFER MCGARRY
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with REGENACR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Jersey City, NJ, US
Jersey City, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lindsay H. Kaplan
Lindsay H. Kaplan L. Kaplan LawP.O. Box 4062Kingston, NY 12402United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Cosmetics, namely, beauty masks; cosmetic kits comprising primarily of non-medicated body lotions, creams, and skin care preparations; cosmetic creams; lotions for cosmetic purposes; cosmetic moisturizing skin lotions, cosmetic revitalizing skin lotions, and cosmetic skin hydrating lotions; cosmetic preparations for skin care; pomades for cosmetic purposes; tissues impregnated with cosmetic lotions; cotton buds for cosmetic purposes; cosmetic kits for skin care comprising primarily of lotions, creams, and preparations for skin care; non-medicated preparations for skin care, namely, skin serum not for medical use; skin care preparations, namely, non-medicated skin serum; non-medicated stimulating lotions for the skin; anti-wrinkle cream for skin care; non-medicated anti-aging serum | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations, namely, solutions for application on and under tissue, bone and organ for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontium growth and bone, organ or tissue regeneration; sanitary preparations for medical purposes; adjuvants for medical purposes; biological preparations for medical purposes, namely the treatment of wounds and damaged skin tissue; pharmaceutical skin lotions; tissues impregnated with pharmaceutical lotions for the treatment of wounds and damaged skin tissue; medical dressings; medicated skin care preparations; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; preparations for medical purposes for cleaning the skin; solution kits for reconstituting allograft tissue; cells for medical or clinical purposes; all-purpose disinfectants; disinfectants for hygiene purposes; kits comprised primarily of chemical reagents used for medical diagnosis; plant extracts other than essential oils, and human and animal tissue and cells in the nature of cell cultures, biological tissue grafts and fresh biological cells, for medical and veterinary use | ACTIVE | — |
| 010 | Surgical apparatus and instruments for medical, dental or veterinary use; surgical and medical apparatus and instruments for use in dentistry, orthopedics, cosmetics, esthetics, general surgery, ophthalmology and mesotherapy; surgical and medical apparatus and instruments for use in cardiovascular, esthetic, cardiac, thoracic, transplantation, head and neck, oral, bone, cartilage, tendon, implant, gastrointestinal, orthopedic, neurosurgical, facial, face-lift and plastic surgery; suture material; syringes for injections; cases fitted for medical instruments; receptacles for applying and administration of medicines, namely, bottles, jars, containers, cannulae, syringes, tubes, infusion and injection devices for administering drugs, platelet-rich plasma, hyaluronic acid, and hydrogels; medical tubing for administering drugs, platelet-rich plasma, hyaluronic acid and hydrogels; syringes for medical use; cases specifically fitted for medical instruments for use by surgeons or doctors; medical specimen containers for storing tissue and biological samples; non-metallic containers specially adapted for transporting and storing organs, tissue and cells for medical purposes; medical injection instruments, namely syringes comprising platelet rich plasma, hyaluronic acid, and silk fibroin; medical instruments, namely, surgical instruments for facilitating the identification, separation or removal of biological tissue; surgical and medical apparatus and instruments used in general surgery; medical apparatus used for taking blood; medical apparatus used for taking blood samples; apparatus used for separating blood components for medical purposes; medical instruments used for filtering blood and blood components; medical apparatus used for introducing pharmaceutical preparations into the human body; medical instruments, namely, surgical instruments for biological tissue; medical devices, namely, surgical instruments for cutting and removing biological tissues; medical apparatus intended for the preparation and processing of platelet concentrate, glycosaminoglycan and polysaccharide hydrogels; surgical cloth tissues in the nature of surgical draping | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 15, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 14, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 14, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 14, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 20, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 16, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 15, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 15, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 15, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 15, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 20, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 20, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 14, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 20, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 21, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 21, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 21, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 14, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 21, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 21, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 21, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 18, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 11, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 5, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 5, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 5, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 5, 2024 | NWAP | NEW APPLICATION ENTERED | — |